SMI Expanded
1.860,57
PKT
+16,43
PKT
+0,89
%
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.07.19 | ams-OSRAM buy | Deutsche Bank AG | |
| 24.07.19 | UBS Hold | Deutsche Bank AG | |
| 24.07.19 | Nestlé Underperform | Credit Suisse Group | |
| 24.07.19 | UBS Outperform | Credit Suisse Group | |
| 24.07.19 | Holcim overweight | JP Morgan Chase & Co. | |
| 24.07.19 | UBS overweight | JP Morgan Chase & Co. | |
| 24.07.19 | ams-OSRAM overweight | Barclays Capital | |
| 24.07.19 | UBS Underweight | Barclays Capital | |
| 24.07.19 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
| 24.07.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 23.07.19 | UBS Neutral | Goldman Sachs Group Inc. | |
| 23.07.19 | Novartis Neutral | UBS AG | |
| 23.07.19 | Zurich Insurance Hold | Deutsche Bank AG | |
| 23.07.19 | ams-OSRAM buy | Hauck & Aufhäuser Privatbankiers KGaA | |
| 23.07.19 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
| 23.07.19 | ams-OSRAM buy | Oddo BHF | |
| 23.07.19 | UBS overweight | JP Morgan Chase & Co. | |
| 23.07.19 | UBS buy | Goldman Sachs Group Inc. | |
| 23.07.19 | UBS Neutral | Goldman Sachs Group Inc. | |
| 22.07.19 | Roche buy | Deutsche Bank AG | |
| 22.07.19 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
| 22.07.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.07.19 | Givaudan buy | Baader Bank | |
| 22.07.19 | Novartis Hold | HSBC | |
| 19.07.19 | Holcim overweight | JP Morgan Chase & Co. | |
| 19.07.19 | Roche buy | Goldman Sachs Group Inc. | |
| 19.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 19.07.19 | Givaudan verkaufen | Credit Suisse Group | |
| 19.07.19 | Novartis Neutral | Credit Suisse Group | |
| 19.07.19 | Swiss Re Sector Perform | RBC Capital Markets | |
| 19.07.19 | Givaudan Hold | Deutsche Bank AG | |
| 19.07.19 | Novartis Hold | Deutsche Bank AG | |
| 19.07.19 | Novartis Underweight | Barclays Capital | |
| 18.07.19 | UBS Neutral | JP Morgan Chase & Co. | |
| 18.07.19 | Nestlé Hold | HSBC | |
| 18.07.19 | Holcim overweight | JP Morgan Chase & Co. | |
| 18.07.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.07.19 | Novartis Neutral | UBS AG | |
| 18.07.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 18.07.19 | Givaudan Neutral | JP Morgan Chase & Co. |